The cytochrome has an unusually low midpoint potential and is postulated to serve as the terminal redox carrier in the transfer of electrons from NADPH to oxygen (4) . Current evidence indicates that the functional oxidase complex also includes multiple other components, including several cytosolic proteins required for activity ofthe otherwise dormant oxidase (5) (6) (7) . Upon cellular stimulation, large quantities of superoxide are formed and converted into toxic oxidants important for microbicidal activity and inflammatory tissue injury.
The phagocyte cytochrome b is a membrane-bound oligomer, probably a heterodimer, of a 91 -kD glycoprotein, gp9 1- phox (also known as the # or heavy chain), and a 22-kD subunit, p22-phox (a or light chain) (8, 9) . The primary amino acid sequences of the heavy and light chains, as deduced from their corresponding cDNAs, have no obvious homology to known proteins, including other cytochromes (10, 1 1), and the functional domains of the two cytochrome subunits have not been defined. The heavy and light chains are closely associated in purified preparations, and denaturation is required to separate the two polypeptides (8, 9) . Despite the close physical interaction of the two cytochrome chains, the corresponding mRNA transcripts appear to be independently regulated. Whereas expression of the 9 1-kD heavy chain transcript is restricted to phagocytic cells, the mRNA for the 22-kD light chain is present in many cell types (10, 11) . Nevertheless, the 22-kD protein is readily detected only in phagocytic cells that also contain the heavy chain (11) . This observation suggests that assembly of the cytochrome heterodimer markedly influences the intracellular stability of its constituent chains. It is uncertain whether low levels ofthe light chain might serve any function in nonphagocytic cells.
Compelling genetic evidence for the functional importance of the phagocyte oxidase and the critical role of cytochrome b is provided by studies of chronic granulomatous disease (CGD).' In this inherited disorder, phagocytic cells are unable to generate superoxide, and affected individuals develop severe and recurrent infections (1, 12) . CGD is genetically heterogenous, reflecting lesions in different components of the oxidase. The 9 l-kD subunit of cytochrome b is encoded by the CYBB locus (for ,B chain) in band Xp2 1.1 (13, 14) . Mutations in this gene result in X-linked recessive CGD (2, 3, 10) , which includes 65% of all cases of CGD, and account for the consistent absence of the cytochrome b heme spectrum originally noted in this subset (15) . Despite the genetic deficiency of only the 9 l-kD subunit, both heavy and light chains are lacking in X-linked CGD (2, 8, 9) , consistent with a model in which intracellular stability of the 22-kD species depends upon association with the larger subunit.
Most autosomal recessive forms of CGD have normal cytochrome b levels (A' CGD) (15) , and lack either p47-phox or p67-phox, two soluble proteins required for intact oxidase function (5) (6) (7) (16) (17) (18) . However, a rare subgroup ofautosomal recessive CGD resembles the X-linked form in that both chains of cytochrome b are absent (A-CGD) (19) . Specific genetic defects in A-CGD have not yet been identified. This subgroup may have mutations in the gene for the 22-kD light chain of cytochrome b, with a secondary lack of the 9 1-kD protein due to failure of cytochrome assembly. Alternatively, the genetic defect might involve other, as yet unidentified proteins, required for expression or assembly of the cytochrome chains.
Here we report the structure ofthe gene for the 22-kD light chain of cytochrome b and its chromosomal location, which serve as a foundation for the analysis of genetic abnormalities at this locus in chronic granulomatous disease. Three unrelated patients with autosomal recessive, cytochrome-negative CGD were studied, and found to have four different mutations in the cytochrome light chain gene.
Methods
Materials. Restriction enzymes were purchased from New England Biolabs, Beverly, MA, and Boehringer-Mannheim, Indianapolis, IN. pUC and M 13 vectors were from Pharmacia Fine Chemicals, Piscataway, NJ, and radiolabeled deoxynucleotides were from Amersham Corp., Arlington Heights, IL. Synthetic nucleotides were prepared on a DNA synthesizer (model 340B; Applied Biosystems, Inc., Foster City, CA). Sequenase (modified T7 polymerase) and kits for DNA sequencing by the dideoxynucleotide chain termination method were from U. S. Biochemicals, Cleveland, OH. Avian myeloblastosis virus reverse transcriptase was obtained from Molecular Genetic Resources, Tampa, FL, and RNAsin from Promega Biotec, Madison, WI. Taq DNA polymerase was from Perkin-Elmer Corp., Norwalk, CT/Cetus Corp., Emeryville, CA. All other reagents used were of analytical grade or better.
Screening ofgenomic library and analysis ofgenomic sequences of 22-kD cytochrome b light chain. A Sau3A partial-digest XEMBL 3A bacteriophage library prepared from human leukocyte DNA (20) was screened by plaque hybridization (21) using a radiolabeled (22) 0.7-kb cDNA probe for the 22-kD cytochrome b light chain (clone 17, which starts 28 nucleotides upstream from the initiator ATG and extends through the poly(A) tail [1 1]). Positive phage clones were plaque purified, and phage DNA analyzed by restriction digests and blot hybridization using established methods (21) . Genomic fragments containing the 22-kD sequence were subcloned into pUC for additional mapping. Intron-exon boundaries were identified by DNA sequence analysis using a Sequenase kit after alkaline denaturation of the plasmid.
Restriction mapping ofgenomic DNA and Northern blot analysis of RNA. High molecular weight genomic DNA was isolated from peripheral blood cell nuclei or tissue culture cells (23) and aliquots digested with restriction enzymes according to the manufacturer's suggestions. Digests were fractionated on a 0.8% agarose gel, transferred to nitrocellulose, and hybridized with the 22-kD cDNA clone 17 probe using standard techniques (21) . RNA was prepared from peripheral blood mononuclear cells using guanidine-HCl precipitation and subjected to denaturing gel electrophoresis for Northern blot analysis as described (24) using cDNA probes for cytochrome b heavy and light chains (1.4-kb Pst I-Eco RI cDNA fragment (10) and clone 17, respectively).
Chromosomal location ofgenefor 22-kD cytochrome b light chain.
DNAs from a panel of rodent-human hybrids containing various human chromosomes (25, 26) were digested with Sac I and subjected to Southern blot analysis, using the 22-kD cDNA clone 17 as a probe. In situ hybridization to metaphase chromosome preparations of normal peripheral blood lymphocytes was performed as described, with tritium-labeled cDNA clone 17 as the probe (27) .
DNA amplification and characterization of amplified sequences.
Amplification primers were 33to 47-mers derived from 22-kD cDNA or genomic sequences, and included restriction enzyme sites at their 5' ends (Bam HI, Eco RI, or Hind III) to facilitate subcloning (Table I) .
Segments of the 22-kD gene were amplified from 1.0-Ag samples of genomic DNA using the polymerase chain reaction (PCR) and Taq DNA polymerase under conditions suggested by the manufacturer, with the following modifications to improve the efficiency of amplification ofsequences high in (G + C) content. The dNTP mix contained 50 MM dGTP and 150 AM 7-deaza-2'-GTP (28); remaining dNTPs were each at 200 MM. Samples were incubated at 940 for I to 1.5 min, then 720 for 3 to 4 minfor a total of 35 to 40 cycles. In the case ofexon 6, sequential amplification of genomic DNA with nested primers 5'GCTCACACrTGCTCCCAGCCTTGGCTCAGCCTACAGA3' (intron V) 12 
5'GGAAGGCGATGCTGATGTTAATGAAA(3' untranslated)
Oligonucleotides 1-12 were used as primers for PCR. Primers 1-6 were derived from the cDNA sequence for the 22-kD light chain of cytochrome b ( 11) and used for amplification of cDNA samples. The number in parentheses indicates the position within the cDNA sequence of the most 5' nucleotide of the primer. Oligonucleotides 7-12 were derived from genomic sequences flanking exons 1, 4, 5, and 6 of the light chain gene (unpublished data), and used to amplify these exons, respectively, from genomic DNA. In addition to the nucleotides displayed here, all primers contained a sequence of 10 nucleotides at their 5' ends that began with 4 random nucleotides followed by a Bam HI, Eco RI, or Hind III restriction site to facilitate subcloning. * Antisense strand.
(primers 5 and 12 followed by primers 5 and 6; Table I ) was performed to generate sufficient product. For analysis of mRNA sequences, first strand cDNA was synthesized from mononuclear cell RNA and amplified by PCR as previously described (24), but with the inclusion of the modifications noted above. As smaller fragments amplified more efficiently, three overlapping fragments of the cDNA sequence were generated for sequence analysis. For DNA sequence analysis, amplified DNA fragments were digested with the appropriate restriction enzymes, purified on a nondenaturing polyacrylamide gel, and cloned into pUC or M 13 derivatives for sequencing. Because of the possibility of heterozygosity, multiple independent clones were sequenced. No random nucleotide substitutions due to misincorporation by Taq polymerase were noted.
Allele-specific hybridization was performed essentially as described (24) to identify single-base substitutions in exons 4, 5, and 6, which were amplified from genomic DNA samples. Allele-specific oligonucleotides (ASO) were prepared for a CAC -* TAC substitution at nucleotide position 242 (numbered with respect to the published cDNA sequence [ 11] ) that predicts a His-72 -Tyr substitution (His-I ASO = CAGAAGCACATGACCGC, Tyr ASO = GCGGTCATG-TACTTCTG [antisense]). In addition, hybridization with an oligonucleotide specific for the alternative histidine codon CAT was examined (His-2 ASO = CAGAAGCATATGACCGC). ASO probes were also prepared for three other substitutions first identified in CGD patients: 
Results
Isolation ofgenomic clones and mapping ofcytochrome b light chain gene. Three independent recombinant XEMBL 3A bacteriophage were isolated from a human genomic library by screening with a cDNA probe containing the entire coding region of the 22-kD light chain mRNA and flanking untranslated sequence ( Fig. 1 A) . A composite restriction map deduced from these clones and genomic Southern blots (see below) is shown in Fig. 1 B. Exon positions were determined by Southern blotting of restriction digests of bacteriophage DNA and hybridization with oligonucleotides derived from the cDNA sequence. Blot hybridization ofbacteriophage DNA with labeled total genomic DNA indicated the widespread distribution ofrepetitive sequences throughout the cloned region. To identify additional restriction sites outside the cloned sequences and to confirm that no gross rearrangements had occurred during the cloning procedure, Southern blotting of genomic DNA digests and hybridization with the cDNA probe was also performed (not shown). The observed fragments were consistent with those predicted from the bacteriophage maps.
The most 5' bacteriophage clone, A9 ( Fig. 1 A) , ended within the coding sequence five nucleotides downstream from the initiator ATG. Repeated screenings of the library failed to yield any clones containing the upstream 5' coding and untranslated sequence. The entire gene appears to be encompassed within two Sac I fragments, as determined by Southern blot hybridization of genomic DNA (not shown), which suggests that the 5' untranslated region and the initiator ATG are within 1.5 kb ofthe 5' end of A9 ( Fig. 1 B) . To determine ifan intron interrupts the sequence near the initiator ATG, we attempted to amplify this region by PCR from genomic DNA. One primer was derived from the 5' untranslated cDNA sequence, and the second primer corresponded to genomic sequence residing 100-130 nucleotides downstream from the 5' end of A9 (primers 1 and 7; Table I ). A 170-bp fragment was amplified, compatible with the lack of any intervening sequence between the initiator ATG and the 5' end of clone A9. This was confirmed by DNA sequencing of the amplified fragment.
As shown in Fig. 1 B, the numbering of light chain exons used in this report designates the exon containing the initiator ATG as "1". However, the existence of additional upstream exons containing 5' untranslated sequence has not been formally excluded.
Exon-intron structure ofcoding region oflight chain gene.
The structure of the entire coding region of the gene for the cytochrome b light chain was characterized by analysis of genomic bacteriophage clones and PCR amplification of genomic DNA, as described above. This region spans 8.5 kb and is divided into six exons (Fig. 1 B) that specify a predicted primary translation product of 195 amino acids. Exons and their corresponding intron boundaries were located and sequenced using genomic clone A9. Table II displays intronexon sizes and their boundary sequences. All splice junction sequences conform to the GT/AG rule (29). Exon 6 encodes the COOH-terminal 72 residues (37% of the protein), a sequence notable for a proline content of 25%, as well as the entire 66-bp 3' untranslated region. The remaining exons each encode 20-25 amino acids.
Identifcation ofa polymorphism at His-72. Comparison of cDNA and genomic sequences revealed a CAC --TAC substitution at nucleotide position 242 of the published cDNA sequence (11) , which predicts the nonconservative replacement of His-72 with a tyrosine residue. Because the histidine residue is a candidate for a coordinating ligand of the heme prosthetic group ofcytochrome b, we investigated whether this sequence discrepancy represented a cloning artefact or a poly- morphism. Exon 4, which contains C/T-242, was amplified from genomic DNA samples obtained from 18 random controls using primers 8 and 9 (Table I) . Hybridization with ASO probes demonstrated that the C T substitution first identified in the genomic bacteriophage clone represented a sequence polymorphism, with each allele detected in normal genomic DNA (representative samples shown in Fig. 2) . None of the samples hybridized with an ASO specific for the alternative histidine codon usage CAT (not shown). Five individuals were homozygous for C-242, the His-72 allele, four were homozygous for T-242, the Tyr-72 allele, and the remaining nine were heterozygous for both alleles. Chromosomal location oflight chain gene. Southern blots of genomic DNA isolated from a panel of human-rodent somatic cell hybrids were probed with cDNA for the human cytochrome b light chain. The presence of human light chain sequences was correlated with the presence of human chromosome 16 (Table III) . To map the light chain gene more precisely, in situ hybridization of metaphase chromosomes was also performed. The results of analysis of 100 metaphase spreads is shown in Fig. 3 . Ofthe 187 silver grains recorded, 14 (7.5%) were located on or near band 16q24.
Mutatations in cytochrome b light chain gene in autosomal recessive, cytochrome-negative CGD. A rare subgroup of autosomal recessive CGD (A-CGD) resembles the X-linked form in that both subunits of cytochrome b are absent in immunoblots of solubilized neutrophils (19) . Specific genetic defects in A-CGD, however, have not yet been identified. We investigated the genetic basis of cytochrome b deficiency in three unrelated patients with this form of CGD. Patient 1, a female, has been reported previously (19, (30) (31) (32) . Her parents were first cousins (both clinically well). There is no known consanguinity in the pedigree of patient 2, a male, who has been reported previously (19, 31, 32) . One of his sisters also had CGD (33) and died from infectious complications. Patient 3, a female, has not previously been reported; her parents are second cousins. Neutrophils from all three patients lack both the 91-and 22-kD cytochrome b polypeptides, and NADPH-oxidase activity is undetectable, with failure of patient membranes to undergo activation in the cell-free oxidase assay even in the presence ofnormal cytosol (19, 31, 32 ; and unpublished results).
We first assessed the expression of mRNAs for the cytochrome subunits in peripheral blood mononuclear cells. As 1 2 (25) shown in Fig. 4 , the 0.8-kb light chain transcript was absent in patient 1, but appeared grossly normal in patient 2 and 3. All three patients had normal levels of the 4.7-kb RNA for the 9 1-kD subunit, indicating that absence of cytochrome b was not due to a primary deficiency ofa transacting factor required for transcription of the heavy chain gene. Southern blot analysis of genomic DNA revealed that the absence ofRNA for the cytochrome b light chain in patient 1 is secondary to a homozygous deletion in the corresponding gene (Fig. 5 ). Hybridization with probes derived from cloned genomic sequences indicated that the 5' end of the deletion occurs near a Bgl II site just downstream from exon 1 (not shown). The minimum size of the deletion is 10 kb, based on the restriction map of the gene and flanking sequences (Fig. 1 B) .
Whether the deletion ends within the mapped region could not be determined because of the existence of repetitive sequences throughout the 3' end of the cloned genomic DNA. Southern blot analysis of genomic DNA digests from patients 2 and 3 using the light chain cDNA probe were normal (not shown).
We next sought evidence for more limited mutations in the coding sequence of the cytochrome b light chain gene in patient 2. cDNA was prepared from mononuclear cell RNA, and specific primers used to amplify the light chain sequence by PCR (see Table I ). Two different alleles were identified by DNA sequence analysis of individual clones, each of which harbored point mutations that predict the synthesis of an abnormal cytochrome b light chain (Fig. 6 ). Allele 1 contained the Tyr-72 polymorphism described above, and in addition, a single nucleotide deletion of a cytosine residue. The deletion predicts a frame-shift of the open reading frame beginning after Gly-8 1, with the mutant protein containing a total of 189 residues. The second allele (allele 2) carried a G --A transition at nucleotide 297 which predicts the nonconservative substitution of a glutamine residue for Arg-90. To confirm these results, the corresponding genomic sequence (exon 4 of the light chain gene) was amplified from DNA prepared from patient 2, and DNA sequencing of individual clones demonstrated the two mutant alleles. Allele-specific hybridization of amplified genomic DNA indicated that patient 2 and his mother were heterozygous for the wild-type Arg-90 and mutant Gln-90 alleles, whereas the father and 24 unrelated normal controls were homozygous for Arg-90 (not shown). The mother is homozygous for the His-72 polymorphism, and the father for Tyr-72 (not shown). We therefore infer that the father is likely to carry allele 1, which contains the Tyr-72 polymorphism and the cytosine deletion, and that the mother carries allele 2.
The sequence of the 22-kD light chain transcript in patient 3 was determined in a similar fashion. A C --A transversion at nucleotide 382 was identified that predicts the nonconservative replacement of Ser-118 with an arginine. Amplification of genomic DNA (exon 5) and DNA sequencing showed that patient 3 was homozygous for the mutant allele. Allele-specific hybridization of amplified DNA from 20 normal controls showed only the wild-type allele, in contrast to patient 3, who was homozygous for Arg-1 18 (not shown). The patient's parents, second cousins, were not available for study. In addition to the mutation at nucleotide 382, patient 3 was homozygous for a C-549 -. T substitution that predicts the conservative replacement of Ala-174 with valine. This substitution appears to be a common polymorphism, as shown by allele-specific hybridization of amplified genomic DNA samples (exon 6) from normal controls (not shown).
The molecular defects in the cytochrome b light chain gene identified in this study are summarized in Table IV .
Discussion
The phagocyte cytochrome b heterodimer is a critical component of the phagocyte oxidase complex that generates superoxide, as its genetic absence in chronic granulomatous disease results in lack of oxidase activity. The 9 1-kD glycoprotein subunit of the cytochrome is encoded by the CYBB locus at Xp21.1 (13, 14) , and the 22-kD light chain locus, designated CYBA, has been mapped in this study to 16q24. Only the Chromosome Number plex, has been localized to 16q22-24 (35) ; there is no obvious cDNA or amino acid sequence homology between this species (36) The location of the heme in the cytochrome b heterodimer has not been conclusively identified, although there is some evidence that the prosthetic group is associated with the light chain. In one recent report, radiation-inactivation target analysis and sedimentation equilibrium studies, both indirect approaches, localized the heme group to the 22-kD subunit (37) . Another group reached the same conclusion after purification of a heme-bearing polypeptide from neutrophils, although this study is problematic in that the amino acid composition of the isolated protein (38) does not resemble that predicted for the 22-kD light chain from its cDNA sequence (11) . In this study, a sequence polymorphism was identified that affects one of the two histidine residues originally noted in the 22-kD polypeptide sequence (11) chain His-72 is not an invariant residue must be taken into account in models for the heme coordinates in the cytochrome b complex. The genetic basis of the rare, autosomally inherited, cytochrome b negative form of CGD has not been previously established. Mutations in the gene for the cytochrome b light chain were identified in all three patients studied in this report (Table IV ). However, it remains possible that some cases of A-CGD result from mutations at other loci encoding as yet unidentified proteins required for cytochrome b expression. In this study, one patient, the product of a consangineous marriage, was homozygous for a large deletion that removed all but the extreme 5' end of the light chain gene. Two other patients carried three different point mutations in the light Figure 6 . Point mutations in 22-kD light chain in a patient with A-CGD. Portions of the light chain coding sequence are shown, along with the encoded amino acid residues, numbered according to their position in the protein sequence (1 1). The wild-type sequence includes a C/T polymorphism. Patient 2 is a compound heterozygote for two different single-base alterations identified in PCR-amplified cDNA and genomic DNA samples (allele 1 and 2). chain gene coding sequence that predict the synthesis of an abnormal polypeptide. One patient was a compound heterozygote for a frame-shift and a missense mutation (Arg-90 -Gln), whereas the other was homozygous for a different nonconservative missense mutation (Ser-1 18 -> Arg). Our data do not directly demonstrate that the missense variants result in a defective cytochrome light chain, as this requires a functional assay for the mutant allele, which is not yet available. However, these mutations did not appear to be polymorphisms and were detected only in the affected patients and the carrier state. Since the cytochrome light chain is absent in immunoblots of neutrophil extracts from these patients, the mutant alleles must direct the synthesis of a polypeptide that is intrinsically unstable or has a defective association with the cytochrome b heavy chain (see below). Both missense mutations reside within a relatively hydrophobic region of the predicted polypeptide, and substitutions in this region might disrupt the normal folding of the light chain or its close interaction with the heavy chain.
It has previously been observed that both the 91and 22-kD subunits of the cytochrome heterodimer are absent in the X-linked and autosomal recessive forms of cytochrome b-negative CGD (19) . X-linked CGD is due to mutations in the gene for the 9 1-kD heavy chain (2, 3), suggesting that intracellular stability of the light chain requires association withthe large subunit. The present findings indicate that the converse may also be true, that is, the 9 1-kD heavy chain is unstable in the absence of binding to the light chain. The stabilizing effect of oligomerization on component polypeptides of multimeric membrane protein complexes has been noted in other systems such as the acetylcholine receptor, the leukocyte integrins, and the T cell receptor (39) (40) (41) . The mRNA transcript for the 22-kD light chain appears to be constitutively expressed in a variety of cell lineages, in contrast to the phagocyte-specific expression of the heavy chain transcript, although levels of 22-kD protein are virtually undetectable in nonphagocytic cells (1 1). Whether low levels of the light chain polypeptide might serve any functional role in nonphagocytic cells has been uncertain. Since the deletion of the majority of the light chain gene produces only the CGD phenotype (patient 1 in this report), it appears unlikely that the 22-kD subunit has any essential function in nonphagocytic cells.
